BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 27693409)

  • 1. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
    AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
    Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly.
    Arpaci D; Karakas Celik S; Can M; Ermiş E; Kuzu F; Kokturk F; Hamamcioglu AC; Dursun A; Bayraktaroglu T
    Redox Rep; 2016 Nov; 21(6):281-6. PubMed ID: 26863932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
    Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
    Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ; Braschi S; Willis G; Astley SB
    Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis.
    Singh S; Verma M; Nain CK; Leelamma CO; Goel RC
    Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina.
    Bharathidevi SR; Babu KA; Jain N; Muthukumaran S; Umashankar V; Biswas J; Angayarkanni N
    Indian J Med Res; 2017 Apr; 145(4):513-520. PubMed ID: 28862184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
    Ramírez-Jiménez R; Martínez-Salazar MF; Almenares-López D; Yáñez-Estrada L; Monroy-Noyola A
    Metab Syndr Relat Disord; 2018 Mar; 16(2):90-96. PubMed ID: 29393817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.
    Zaragoza-García O; Guzmán-Guzmán IP; Moreno-Godínez ME; Navarro-Zarza JE; Antonio-Vejar V; Ramírez M; Parra-Rojas I
    Clin Rheumatol; 2021 Feb; 40(2):741-752. PubMed ID: 32556934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis.
    Bayrak A; Bayrak T; Tokgözoglu SL; Volkan-Salanci B; Deniz A; Yavuz B; Alikasifoglu M; Demirpençe E
    J Atheroscler Thromb; 2012; 19(4):376-84. PubMed ID: 22188760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in age-related macular degeneration.
    Ates O; Azizi S; Alp HH; Kiziltunc A; Beydemir S; Cinici E; Kocer I; Baykal O
    Tohoku J Exp Med; 2009 Jan; 217(1):17-22. PubMed ID: 19155603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration.
    Paun CC; Ersoy L; Schick T; Groenewoud JM; Lechanteur YT; Fauser S; Hoyng CB; de Jong EK; den Hollander AI
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7766-73. PubMed ID: 26641553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.
    Zargari M; Sharafeddin F; Mahrooz A; Alizadeh A; Masoumi P
    Exp Biol Med (Maywood); 2016 Aug; 241(14):1489-96. PubMed ID: 27022137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.
    Bortolasci CC; Vargas HO; Souza-Nogueira A; Barbosa DS; Moreira EG; Nunes SO; Berk M; Dodd S; Maes M
    J Affect Disord; 2014 Apr; 159():23-30. PubMed ID: 24679385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
    Agachan B; Yilmaz H; Karaali Z; Isbir T
    Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.